Current practice of diagnosis and reporting of prostate cancer on needle biopsy among genitourinary pathologists

Human Pathology

Volumn 37, Issue 3, 2006, Pages 292-297

  Egevad, Lars ^a   Allsbrook Jr , William C ^b   Epstein, Jonathan I ^c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Human; Male; Pathology; Prostatic neoplasms

Indexed keywords

2 METHYLACYL COENZYME A RACEMASE; CYTOKERATIN; FORMALDEHYDE; PROTEIN P63;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GROWTH; CANCER INVASION; CANCER SIZE; CLINICAL FEATURE; CONTROLLED STUDY; GLEASON SCORE; GLOMERULOPATHY; HUMAN; IMMUNOHISTOCHEMISTRY; MEDICAL PRACTICE; MOLECULAR WEIGHT; NEEDLE BIOPSY; NORMAL HUMAN; PATHOLOGIST; PROSTATE CANCER; QUANTITATIVE ANALYSIS; QUESTIONNAIRE; TISSUE SECTION; TUMOR BIOPSY;

BIOPSY, NEEDLE; CLINICAL COMPETENCE; HUMANS; MALE; PATHOLOGY, CLINICAL; PHYSICIAN'S PRACTICE PATTERNS; PROSTATE; PROSTATIC NEOPLASMS; QUESTIONNAIRES;

EID: 33244476970     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2005.10.011     Document Type: Article

References (26)

1. L. Egevad, W.C. Allsbrook Jr, and J.I. Epstein Current practice of Gleason grading among genitourinary pathologists Hum Pathol 36 2005 5 9
2. S.J. Freedland, W.J. Aronson, and M.K. Terris The percentage of prostate needle biopsy cores with carcinoma from the more involved side of the biopsy as a predictor of prostate specific antigen recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database Cancer 98 2003 2344 2350
3. M.W. Kattan, J.A. Eastham, and T.M. Wheeler Counseling men with prostate cancer: a nomogram for predicting the presence of small, moderately differentiated, confined tumors J Urol 170 2003 1792 1797
4. A.J. Egan, and D.G. Bostwick Prediction of extraprostatic extension of prostate cancer based on needle biopsy findings: perineural invasion lacks significance on multivariate analysis Am J Surg Pathol 21 1997 1496 1500
5. J.I. Epstein, and S.R. Potter The pathological interpretation and significance of prostate needle biopsy findings: implications and current controversies J Urol 166 2001 402 410
6. D.G. Bostwick, D.J. Grignon, and M.E. Hammond Prognostic factors in prostate cancer. College of American Pathologists Consensus Statement 1999 Arch Pathol Lab Med 124 2000 995 1000
7. L. Boccon-Gibod, T.H. van der Kwast, R. Montironi, and A. Bono Handling and pathology reporting of prostate biopsies Eur Urol 46 2004 177 181
8. W.M. Murphy, J. Ramsey, and M.S. Soloway A better nuclear fixative for diagnostic bladder and prostate biopsies J Urol Pathol 1 1993 79 87
9. R.B. Shah, M. Zhou, M. LeBlanc, M. Snyder, and M.A. Rubin Comparison of the basal cell-specific markers, 34betaE12 and p63, in the diagnosis of prostate cancer Am J Surg Pathol 26 2002 1161 1168
10. M. Zhou, R. Shah, R. Shen, and M.A. Rubin Basal cell cocktail (34betaE12 + p63) improves the detection of prostate basal cells Am J Surg Pathol 27 2003 365 371
11. Z. Jiang, B.A. Woda, and K.L. Rock P504S: a new molecular marker for the detection of prostate carcinoma Am J Surg Pathol 25 2001 1397 1404
12. M. Zhou, H. Aydin, H. Kanane, and J.I. Epstein How often does alpha-methylacyl-CoA-racemase contribute to resolving an atypical diagnosis on prostate needle biopsy beyond that provided by basal cell markers? Am J Surg Pathol 28 2004 239 243
13. R. Green, and J.I. Epstein Use of intervening unstained slides for immunohistochemical stains for high molecular weight cytokeratin on prostate needle biopsies Am J Surg Pathol 23 1999 567 570
14. B.L. Baisden, H. Kahane, and J.I. Epstein Perineural invasion, mucinous fibroplasia, and glomerulations: diagnostic features of limited cancer on prostate needle biopsy Am J Surg Pathol 23 1999 918 924
15. A. Pacelli, A. Lopez-Beltran, A.J. Egan, and D.G. Bostwick Prostatic adenocarcinoma with glomeruloid features Hum Pathol 29 1998 543 546
16. M. Varma, M.W. Lee, and P. Tamboli Morphologic criteria for the diagnosis of prostatic adenocarcinoma in needle biopsy specimens. A study of 250 consecutive cases in a routine surgical pathology practice Arch Pathol Lab Med 126 2002 554 561
17. D.G. Bostwick, P. Wollan, and K. Adlakha Collagenous micronodules in prostate cancer. A specific but infrequent diagnostic finding Arch Pathol Lab Med 119 1995 444 447
18. J.I. Epstein Diagnostic criteria of limited adenocarcinoma of the prostate on needle biopsy Hum Pathol 26 1995 223 229
19. P.H. Carstens Perineural glands in normal and hyperplastic prostates J Urol 123 1980 686 688
20. R.J. Cohen, and S. Stables Intraprostatic fat Hum Pathol 29 1998 424 425
21. L. Egevad, B.J. Norlen, and M. Norberg The value of multiple core biopsies for predicting the Gleason score of prostate cancer BJU Int 88 2001 716 721
22. M.A. Rubin, R. Dunn, N. Kambham, C.P. Misick, and K.M. O'Toole Should a Gleason score be assigned to a minute focus of carcinoma on prostate biopsy? Am J Surg Pathol 24 2000 1634 1640
23. J.I. Epstein Gleason score 2-4 adenocarcinoma of the prostate on needle biopsy: a diagnosis that should not be made Am J Surg Pathol 24 2000 477 478
24. M. Amin, L. Boccon-Gibod, and L. Egevad Prognostic and predictive factors and reporting of prostate carcinoma in prostate needle biopsy specimens Scand J Urol Nephrol Suppl 216 2005 20 33
25. M.R. Cupp, D.G. Bostwick, R.P. Myers, and J.E. Oesterling The volume of prostate cancer in the biopsy specimen cannot reliably predict the quantity of cancer in the radical prostatectomy specimen on an individual basis J Urol 153 1995 1543 1548
26. M. Noguchi, T.A. Stamey, J.E. McNeal, and C.M. Yemoto Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer J Urol 166 2001 104 109